DTaP-Hib-IPV

BIOLOGICAL3 trials

Sponsors

Novartis Vaccines

Conditions

HealthyMeningococcal DiseaseMeningococcal Meningitis

Phase 2

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

CompletedNCT00310856

Novartis VaccinesMeningococcal Meningitis

Start: 2005-06-30End: 2006-11-30Updated: 2018-10-09

Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

CompletedNCT00381615

Novartis VaccinesHealthy

Start: 2006-09-30End: 2008-08-31Updated: 2015-10-09

B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants

CompletedNCT00488683

Novartis VaccinesMeningococcal Disease

Start: 2007-07-31End: 2009-06-30Updated: 2014-10-01